PNC Financial Services Group’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $74.6K | Buy |
2,377
+757
| +47% | +$31.9K | ﹤0.01% | 3104 |
|
|
2026
Q1 | $89.6K | Buy |
1,620
+60
| +4% | +$2.86K | ﹤0.01% | 2886 |
|
|
2025
Q4 | $58.3K | Sell |
1,560
-121
| -7% | -$4.92K | ﹤0.01% | 3122 |
|
|
2025
Q3 | $68K | Buy |
1,681
+93
| +6% | +$3.07K | ﹤0.01% | 3031 |
|
|
2025
Q2 | $40.6K | Sell |
1,588
-83
| -5% | -$1.81K | ﹤0.01% | 3226 |
|
|
2025
Q1 | $35.7K | Buy |
1,671
+97
| +6% | +$2.17K | ﹤0.01% | 3273 |
|
|
2024
Q4 | $33.1K | Buy |
1,574
+107
| +7% | +$2.48K | ﹤0.01% | 3315 |
|
|
2024
Q3 | $33K | Buy |
1,467
+180
| +14% | +$3.48K | ﹤0.01% | 3286 |
|
|
2024
Q2 | $21.6K | Buy |
1,287
+34
| +3% | +$546 | ﹤0.01% | 3445 |
|
|
2024
Q1 | $16.2K | Buy |
1,253
+293
| +31% | +$3.51K | ﹤0.01% | 3553 |
|
|
2023
Q4 | $11.1K | Sell |
960
-1,327
| -58% | -$15K | ﹤0.01% | 3691 |
|
|
2023
Q3 | $29.2K | Sell |
2,287
-763
| -25% | -$10.8K | ﹤0.01% | 3223 |
|
|
2023
Q2 | $41.8K | Buy |
3,050
+764
| +33% | +$10.9K | ﹤0.01% | 3169 |
|
|
2023
Q1 | $35K | Sell |
2,286
-192
| -8% | -$2.93K | ﹤0.01% | 3182 |
|
|
2022
Q4 | $33.2K | Buy |
2,478
+1,188
| +92% | +$15.9K | ﹤0.01% | 3212 |
|
|
2022
Q3 | $18K | Buy |
1,290
+506
| +65% | +$8.74K | ﹤0.01% | 3497 |
|
|
2022
Q2 | $16K | Sell |
784
-7
| -0.9% | -$133 | ﹤0.01% | 3602 |
|
|
2022
Q1 | $17K | Buy |
791
+22
| +3% | +$444 | ﹤0.01% | 3652 |
|
|
2021
Q4 | $17K | Sell |
769
-97
| -11% | -$2.07K | ﹤0.01% | 3613 |
|
|
2021
Q3 | $19K | Sell |
866
-33
| -4% | -$794 | ﹤0.01% | 3526 |
|
|
2021
Q2 | $26K | Sell |
899
-28
| -3% | -$757 | ﹤0.01% | 3364 |
|
|
2021
Q1 | $24K | Buy |
927
+119
| +15% | +$2.69K | ﹤0.01% | 3342 |
|
|
2020
Q4 | $16K | Buy |
808
+169
| +26% | +$3.11K | ﹤0.01% | 3427 |
|
|
2020
Q3 | $11K | Sell |
639
-823
| -56% | -$17.6K | ﹤0.01% | 3470 |
|
|
2020
Q2 | $38K | Sell |
1,462
-886
| -38% | -$22K | ﹤0.01% | 2903 |
|
|
2020
Q1 | $57K | Buy |
2,348
+840
| +56% | +$20.5K | ﹤0.01% | 2549 |
|
|
2019
Q4 | $38K | Buy |
1,508
+826
| +121% | +$19.2K | ﹤0.01% | 3051 |
|
|
2019
Q3 | $14K | Sell |
682
-237
| -26% | -$6.49K | ﹤0.01% | 3467 |
|
|
2019
Q2 | $29K | Sell |
919
-256
| -22% | -$8.03K | ﹤0.01% | 3201 |
|
|
2019
Q1 | $39K | Buy |
1,175
+77
| +7% | +$2.4K | ﹤0.01% | 3078 |
|
|
2018
Q4 | $35K | Buy |
1,098
+42
| +4% | +$1.58K | ﹤0.01% | 3055 |
|
|
2018
Q3 | $46K | Buy |
1,056
+12
| +1% | +$567 | ﹤0.01% | 3043 |
|
|
2018
Q2 | $49K | Buy |
1,044
+501
| +92% | +$22.2K | ﹤0.01% | 2988 |
|
|
2018
Q1 | $21K | Buy |
543
+72
| +15% | +$2.67K | ﹤0.01% | 3415 |
|
|
2017
Q4 | $15K | Buy |
471
+309
| +191% | +$11K | ﹤0.01% | 3532 |
|
|
2017
Q3 | $6K | Buy |
162
+9
| +6% | +$338 | ﹤0.01% | 3821 |
|
|
2017
Q2 | $6K | Buy |
153
+56
| +58% | +$1.83K | ﹤0.01% | 3754 |
|
|
2017
Q1 | $3K | Buy |
97
+89
| +1,113% | +$2.51K | ﹤0.01% | 3870 |
|
|
2016
Q4 | $0 | Buy |
+8
| New | +$218 | ﹤0.01% | 4063 |
|
|
2016
Q3 | – | Sell |
-62
| Closed | -$1K | – | 4199 |
|
|
2016
Q2 | $1K | Sell |
62
-63
| -50% | -$1.31K | ﹤0.01% | 4364 |
|
|
2016
Q1 | $3K | Buy |
125
+23
| +23% | +$659 | ﹤0.01% | 4062 |
|
|
2015
Q4 | $3K | Hold |
102
| – | – | ﹤0.01% | 4051 |
|
|
2015
Q3 | $3K | Buy |
102
+3
| +3% | +$110 | ﹤0.01% | 4160 |
|
|
2015
Q2 | $4K | Buy |
99
+38
| +62% | +$1.31K | ﹤0.01% | 4177 |
|
|
2015
Q1 | $2K | Hold |
61
| – | – | ﹤0.01% | 4315 |
|
|
2014
Q4 | $2K | Buy |
+61
| New | +$1.69K | ﹤0.01% | 3813 |
|
Other funds holding PAHC
HAI
CCMINC
PNC Financial Services Group's PAHC Position: Q2 2026 in Review
PNC Financial Services Group increased its Phibro Animal Health (PAHC) stake by 47% in Q2 2026, buying an estimated $31.9K and bringing the position to 2,377 shares worth $74.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3104.
PNC Financial Services Group first reported a position in PAHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $89.6K in Q1 2026. 78 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- PNC Financial Services Group held 2,377 shares of Phibro Animal Health worth $74.6K as of Q2 2026.
- PNC Financial Services Group bought 757 Phibro Animal Health shares in Q2 2026, an estimated $31.9K.
- Phibro Animal Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3104 holding.
- PNC Financial Services Group first reported a position in Phibro Animal Health in Q4 2014 and has held it in 46 quarters since.
- PNC Financial Services Group's Phibro Animal Health position peaked at $89.6K in Q1 2026.
- 78 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.